Two experimental coronavirus vaccines by German biotech firm BioNTech and US pharmaceutical giant Pfizer have received the US Food and Drug Administration's "fast track" designation.
The vaccines, BNT162b1 and BNT162b2, are the two most advanced of the four vaccines being developed by the companies.
No comments:
Post a Comment